Clinical use of recombinant human erythropoietin (rHuEPO) in the treatment of preterm anaemia;Uso clinico dell'eritropoietina umana ricombinante (rHuEPO) nell'anemia della prematurità

Rivista Italiana di Pediatria

Volumn 24, Issue 3 SUPPL., 1998, Pages 442-449

  Corona, G ^a   Fulia, F ^a   Liotta, C ^a   Barberi, I ^a,b  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Anaemia of prematurity; Erythropoiesis; Recombinant Human Erythropoietin

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; IRON; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ARTICLE; BIRTH WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFICACY; ERYTHROPOIESIS; FEMALE; GESTATIONAL AGE; HUMAN; IRON BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NEWBORN; PREMATURITY; RANDOMIZED CONTROLLED TRIAL; RETICULOCYTE; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031830697     PISSN: 03925161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Shannon KM. Anemia of prematurity: progress and prospects. Ann J Pediatr Hematol Oncol 1990;12:14-20.
2. Wardrop C, Holland B, Veale K, Jones J, Gray O. Nonphysiologic anaemia of prematurity. Arch Dis Child 1978;53;855-860.
3. Stockman J, Garcia J, Oski F. The anemia of prematurity: factors governing the erythropoietin response. N Engl J Med 1977;296:647-650.
4. Shannon K, Naylor G, Torkildson JC, et al. Circulating erythroid progenitors in the anemia of prematurity. N Engl J Med 1987;317:728-733.
5. Rhondeau S, Christensen R, Ross M, Rhotstein G, Simmons M. Responsivennes to recombinant human erythropoietin of marrow erythroid progenitors from infants with the anemia of prematurity. J Pediatr 1988;112:935-940.
6. Stockman JA III. Erythropoietin: off again, on again. J Pediatr 1988;112:906-908.
7. Halperin D, Wacker P, Lacourt G, et al. Effects of recombinant erythropoietin in infants with anemia of prematurity: a pilot study. J. Pediatr 1990;116:779-780.
8. Meyer MP, Meyer JH, Commerford A, et al. Recombinant human erythropoietin in treatment of the anemia of prematurity: results of a duble-blind, placebo controlled study. Pediatrics 1994;93:918-923.
9. Ohls R, Christensen R. Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity. J Pediatr 1991;119:781-788.
10. Shannon KM, et al. Recombinant human erythropoietin in the anemia of prematurity. Results of a placebo-controlled pilot study. J Pediat 1991;118:949-955.
11. Carnielli V, Montini G, Da Riol R, Dall'Amico R, Cantarutti F. Effects of higth doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants. J Pediatr 1992;121:98-102.
12. Messer J, Haddad J, Donato L, Astruc D, Matis J. Early treatment of premature infants with recombinant human erythropoietin. Pediatrics 1992;92:519-523.
13. Shannon KM. Recombinant erythropoietin in pediatrics. A clinical perspective. Pediatr Ann 1990;19:197-206.
14. Corona G, Fulia F, Mondio M, Cannatelli L, Cordaro V, Barberi I. Eosinofilia transitoria in corso di trattamento con eritropoietina umana ricombinante. Societä di Medicina Perinatale. V Congresso Nazionale. Venezia: Monduzzi Editore 1994:199-204.
15. Shannon KM, Keith III JF, Mentzer WC, et al. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusion in very low birth weight infants. Pediatrics 1995;95:1-8.
16. Emmerson AJB, Coles HJ, Stern CMM, Pearson TC. Double blind trial of recombinant human erythropoietin in preterm infants. Arch Dis Child 1993;68:291-296.
17. Shannon KM. Recombinant erythropoietin in the anemia of prematurity: five years later. Pediatr 1993;92:614-616.
18. Corona G, Fulia F, Liotta C, Cannatelli L, Betto A, Bonarrigo A, Cordaro V, Barberi I. Valutazione dei costi/benefici del trattamento con rHuEPO nell'anemia della prematurità. XXII Congresso Nazionale AIEOP. Trieste 30-31 maggio-1 giugno 1996.